This study was performed to examine the anticancer potential of Calebin A and whether Calebin A suppresses the TNF-β-promoted p65-NF-κB activation and NF-κB-mediated gene products in colorectal cancer cells. This evidence concerns the gene NFKB1 and colorectal cancer.